1. Home
  2. JSPRW
  3. JSPRW News

Latest Japer Therapeutics Inc. (JSPRW) News on February 22, 2025

Jasper Therapeutics Announces Briquilimab Presentations at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting
JSPRW

GlobeNewswire

12 days ago

Jasper Therapeutics Announces Briquilimab Presentations at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting

Jasper Therapeutics to Present at the Oppenheimer Healthcare Life Sciences Conference
JSPRW

GlobeNewswire

18 days ago

Jasper Therapeutics to Present at the Oppenheimer Healthcare Life Sciences Conference

Jasper Therapeutics Reports Positive Data from BEACON Study of Briquilimab in Chronic Spontaneous Urticaria
JSPRW

GlobeNewswire

a month ago

Jasper Therapeutics Reports Positive Data from BEACON Study of Briquilimab in Chronic Spontaneous Urticaria

Jasper Therapeutics to Host Webinar to Present Preliminary Data from the BEACON Study of Briquilimab in Chronic Spontaneous Urticaria on January 8, 2025
JSPRW

GlobeNewswire

2 months ago

Jasper Therapeutics to Host Webinar to Present Preliminary Data from the BEACON Study of Briquilimab in Chronic Spontaneous Urticaria on January 8, 2025

Jasper Therapeutics Announces First Patient Dosed in Phase 1b/2a ETESIAN Clinical Study of Briquilimab in Asthma
JSPRW

GlobeNewswire

3 months ago

Jasper Therapeutics Announces First Patient Dosed in Phase 1b/2a ETESIAN Clinical Study of Briquilimab in Asthma

We're Keeping An Eye On Jasper Therapeutics' (NASDAQ:JSPR) Cash Burn Rate
JSPRW

Simply Wall St.

3 months ago

We're Keeping An Eye On Jasper Therapeutics' (NASDAQ:JSPR) Cash Burn Rate

Jasper Therapeutics to Participate at Upcoming Investor Conferences
JSPRW

GlobeNewswire

3 months ago

Jasper Therapeutics to Participate at Upcoming Investor Conferences

Analysts Bullish on Jasper Therapeutics as Briquilimab Trials Show Promise
JSPRW

GuruFocus.com

3 months ago

Analysts Bullish on Jasper Therapeutics as Briquilimab Trials Show Promise

Jasper Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
JSPRW

GlobeNewswire

3 months ago

Jasper Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Jasper Therapeutics to Present Preclinical Briquilimab Data at the American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting
JSPRW

GlobeNewswire

4 months ago

Jasper Therapeutics to Present Preclinical Briquilimab Data at the American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting

Jasper Therapeutics Announces Further Expansion of Clinical Program in Chronic Spontaneous Urticaria
JSPRW

GlobeNewswire

4 months ago

Jasper Therapeutics Announces Further Expansion of Clinical Program in Chronic Spontaneous Urticaria

Jasper Therapeutics Reports Positive Data from SPOTLIGHT Study of Briquilimab in Chronic Inducible Urticaria
JSPRW

GlobeNewswire

4 months ago

Jasper Therapeutics Reports Positive Data from SPOTLIGHT Study of Briquilimab in Chronic Inducible Urticaria

Jasper Therapeutics Announces Health Canada Clearance of Clinical Trial Application for Phase 1b/2a Study of Briquilimab in Asthma
JSPRW

GlobeNewswire

5 months ago

Jasper Therapeutics Announces Health Canada Clearance of Clinical Trial Application for Phase 1b/2a Study of Briquilimab in Asthma

Jasper Therapeutics to Present at Present at Upcoming September Investor Conferences
JSPRW

GlobeNewswire

6 months ago

Jasper Therapeutics to Present at Present at Upcoming September Investor Conferences

Jasper Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Developments
JSPRW

GlobeNewswire

6 months ago

Jasper Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Developments

Jasper Therapeutics Announces Appointment of Svetlana Lucas Ph.D., to its Board of Directors
JSPRW

GlobeNewswire

8 months ago

Jasper Therapeutics Announces Appointment of Svetlana Lucas Ph.D., to its Board of Directors

Jasper Therapeutics to Present at the Oppenheimer Novel Targets in Immunology Summit
JSPRW

GlobeNewswire

8 months ago

Jasper Therapeutics to Present at the Oppenheimer Novel Targets in Immunology Summit

Jasper Therapeutics Presents Data from Preclinical Briquilimab Study at the 2024 EHA Hybrid Congress
JSPRW

GlobeNewswire

8 months ago

Jasper Therapeutics Presents Data from Preclinical Briquilimab Study at the 2024 EHA Hybrid Congress

Here's Why We're Not Too Worried About Jasper Therapeutics' (NASDAQ:JSPR) Cash Burn Situation
JSPRW

Simply Wall St.

8 months ago

Here's Why We're Not Too Worried About Jasper Therapeutics' (NASDAQ:JSPR) Cash Burn Situation

Jasper Therapeutics to Present Data on Briquilimab in Mast Cell Driven Diseases at the EAACI Congress 2024
JSPRW

GlobeNewswire

9 months ago

Jasper Therapeutics to Present Data on Briquilimab in Mast Cell Driven Diseases at the EAACI Congress 2024

Jasper Therapeutics to Present at the Jefferies Global Healthcare Conference
JSPRW

GlobeNewswire

9 months ago

Jasper Therapeutics to Present at the Jefferies Global Healthcare Conference

Jasper Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Developments
JSPRW

GlobeNewswire

9 months ago

Jasper Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Developments

Jasper Therapeutics Announces Briquilimab Development Program in Asthma
JSPRW

GlobeNewswire

9 months ago

Jasper Therapeutics Announces Briquilimab Development Program in Asthma

Jasper Therapeutics to Present at Upcoming Investor Conferences in May
JSPRW

GlobeNewswire

10 months ago

Jasper Therapeutics to Present at Upcoming Investor Conferences in May

Jasper Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
JSPRW

GlobeNewswire

a year ago

Jasper Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference

Jasper Therapeutics to Participate in the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference
JSPRW

GlobeNewswire

a year ago

Jasper Therapeutics to Participate in the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference

Jasper Therapeutics Announces First Patient Dosed in Phase 1b/2a SPOTLIGHT Clinical Study of Briquilimab in Chronic Inducible Urticaria
JSPRW

GlobeNewswire

a year ago

Jasper Therapeutics Announces First Patient Dosed in Phase 1b/2a SPOTLIGHT Clinical Study of Briquilimab in Chronic Inducible Urticaria

New Positive Data Presented on Briquilimab Conditioning in Patients with Fanconi Anemia
JSPRW

GlobeNewswire

a year ago

New Positive Data Presented on Briquilimab Conditioning in Patients with Fanconi Anemia

Jasper Therapeutics Reports Fiscal 2023 Financial Results and Recent Corporate Developments
JSPRW

GlobeNewswire

a year ago

Jasper Therapeutics Reports Fiscal 2023 Financial Results and Recent Corporate Developments

Jasper Therapeutics to Present at the 43rd Annual TD Cowen Healthcare Conference
JSPRW

GlobeNewswire

a year ago

Jasper Therapeutics to Present at the 43rd Annual TD Cowen Healthcare Conference

Jasper Therapeutics Presents Data from Preclinical Briquilimab Studies at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting
JSPRW

GlobeNewswire

a year ago

Jasper Therapeutics Presents Data from Preclinical Briquilimab Studies at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting

Jasper Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Conference
JSPRW

GlobeNewswire

a year ago

Jasper Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Conference

Jasper Therapeutics Announces Pricing of $50 Million Underwritten Offering of Common Stock
JSPRW

GlobeNewswire

a year ago

Jasper Therapeutics Announces Pricing of $50 Million Underwritten Offering of Common Stock

Jasper Therapeutics Announces Preclinical Data Presentations at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting
JSPRW

GlobeNewswire

a year ago

Jasper Therapeutics Announces Preclinical Data Presentations at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting

Jasper Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
JSPRW

GlobeNewswire

a year ago

Jasper Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Traefik Labs Appoints Sudeep Goswami as CEO, Founder Emile Vauge Transitions to Chief Technology Officer
JSPRW

Business Wire

a year ago

Traefik Labs Appoints Sudeep Goswami as CEO, Founder Emile Vauge Transitions to Chief Technology Officer

Gas prices in 'glacial grind higher' for now — here's why
JSPRW

Yahoo Finance

a year ago

Gas prices in 'glacial grind higher' for now — here's why

GM to halve spending on troubled robotaxi unit Cruise in 2024
JSPRW

Reuters

a year ago

GM to halve spending on troubled robotaxi unit Cruise in 2024

Avanti Senior Living Partners with Icon to Enhance Residents’ Experience By Leveraging Cutting-Edge Technology
JSPRW

Business Wire

a year ago

Avanti Senior Living Partners with Icon to Enhance Residents’ Experience By Leveraging Cutting-Edge Technology

RBC Bearings Incorporated's (NYSE:RBC) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
JSPRW

Simply Wall St.

a year ago

RBC Bearings Incorporated's (NYSE:RBC) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Soluna Announces Monthly Business Update
JSPRW

Business Wire

a year ago

Soluna Announces Monthly Business Update

Foresight: Rail Vision Receives Order from Leading US-based Rail Contractor of up to $5 Million
JSPRW

GlobeNewswire

a year ago

Foresight: Rail Vision Receives Order from Leading US-based Rail Contractor of up to $5 Million

OMH: Takeaways From Simply Sakal Acquisition
JSPRW

Zacks Small Cap Research

a year ago

OMH: Takeaways From Simply Sakal Acquisition

Reborn Coffee Secures $1 Million Private Placement Equity Commitment from Chairman Farooq Arjomand, Catalyzing International Growth Initiatives
JSPRW

GlobeNewswire

a year ago

Reborn Coffee Secures $1 Million Private Placement Equity Commitment from Chairman Farooq Arjomand, Catalyzing International Growth Initiatives

Jasper Therapeutics Highlights Recent Accomplishments and Key Upcoming Milestones
JSPRW

GlobeNewswire

a year ago

Jasper Therapeutics Highlights Recent Accomplishments and Key Upcoming Milestones

JSPRW

GlobeNewswire

a year ago

BIMI Announces Results of 2023 Annual General Meeting of Stockholders

Jasper Therapeutics, Inc. Announces Reverse Stock Split
JSPRW

GlobeNewswire

a year ago

Jasper Therapeutics, Inc. Announces Reverse Stock Split

Turbo Energy Announces Interim Results for the Period Ended June 30, 2023
JSPRW

GlobeNewswire

a year ago

Turbo Energy Announces Interim Results for the Period Ended June 30, 2023

Versus Systems Announces 1-For-16 Reverse Stock Split to Aid Compliance with Nasdaq Listing Requirements
JSPRW

GlobeNewswire

a year ago

Versus Systems Announces 1-For-16 Reverse Stock Split to Aid Compliance with Nasdaq Listing Requirements

OPTICAL CABLE CORPORATION SCHEDULES CONFERENCE CALL TO DISCUSS FOURTH QUARTER AND FISCAL YEAR 2023 RESULTS
JSPRW

PR Newswire

a year ago

OPTICAL CABLE CORPORATION SCHEDULES CONFERENCE CALL TO DISCUSS FOURTH QUARTER AND FISCAL YEAR 2023 RESULTS

JSPRW

GlobeNewswire

a year ago

BIMI International Medical Inc. Announces Third Quarter 2023 Financial Results

Cyclacel Pharmaceuticals Reports Fadraciclib Phase 1 Data Suggesting Efficacy Against Tumors With CDKN2A, CDKN2B and MTAP Deletions
JSPRW

GlobeNewswire

a year ago

Cyclacel Pharmaceuticals Reports Fadraciclib Phase 1 Data Suggesting Efficacy Against Tumors With CDKN2A, CDKN2B and MTAP Deletions

BioVie Inc. (BIVI) Loses -46.95% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
JSPRW

Zacks

a year ago

BioVie Inc. (BIVI) Loses -46.95% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Jasper Therapeutics Presents Positive Final Results from Phase 1 Study of Briquilimab in Patients with AML or MDS Undergoing Hematopoietic Cell Transplant in Oral Presentation at ASH 2023
JSPRW

GlobeNewswire

a year ago

Jasper Therapeutics Presents Positive Final Results from Phase 1 Study of Briquilimab in Patients with AML or MDS Undergoing Hematopoietic Cell Transplant in Oral Presentation at ASH 2023

Water Tower Research US Climate Virtual Investor Conference: Presentations Now Available for Online Viewing
JSPRW

GlobeNewswire

a year ago

Water Tower Research US Climate Virtual Investor Conference: Presentations Now Available for Online Viewing

Neonode (NASDAQ:NEON) Is In A Good Position To Deliver On Growth Plans
JSPRW

Simply Wall St.

a year ago

Neonode (NASDAQ:NEON) Is In A Good Position To Deliver On Growth Plans

Marin Software Launches Support for Qihoo 360, Expanding Options for Advertisers Focused on China
JSPRW

Business Wire

a year ago

Marin Software Launches Support for Qihoo 360, Expanding Options for Advertisers Focused on China

Jasper Announces First Patient Dosed in Phase 1b/2a Clinical Study of Briquilimab in Chronic Spontaneous Urticaria
JSPRW

GlobeNewswire

a year ago

Jasper Announces First Patient Dosed in Phase 1b/2a Clinical Study of Briquilimab in Chronic Spontaneous Urticaria

JSPRW

GlobeNewswire

a year ago

BIMI Announces Buyback of Warrants

JSPRW

GlobeNewswire

a year ago

BIMI Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)

JSPRW

GlobeNewswire

a year ago

BIMI International Medical Inc. Announces Second Quarter 2023 Financial Results

Wheeler Will Likely Issue Unregistered Common Stock to Settle December Redemption Requests
JSPRW

ACCESSWIRE

a year ago

Wheeler Will Likely Issue Unregistered Common Stock to Settle December Redemption Requests

The Returns At Tile Shop Holdings (NASDAQ:TTSH) Aren't Growing
JSPRW

Simply Wall St.

a year ago

The Returns At Tile Shop Holdings (NASDAQ:TTSH) Aren't Growing

Lucid Diagnostics Inc. (NASDAQ:LUCD) Q3 2023 Earnings Call Transcript
JSPRW

Insider Monkey

a year ago

Lucid Diagnostics Inc. (NASDAQ:LUCD) Q3 2023 Earnings Call Transcript

ToughBuilt Industries Announces Third Quarter 2023 Results
JSPRW

GlobeNewswire

a year ago

ToughBuilt Industries Announces Third Quarter 2023 Results

JSPRW

GuruFocus.com

a year ago

Jasper Therapeutics Inc (JSPR) Reports Q3 2023 Financial Results and Business Progress

AgEagle to Showcase Its Drone Innovations at Renowned Milipol Homeland Security Event and Modern Warfare Week
JSPRW

GlobeNewswire

a year ago

AgEagle to Showcase Its Drone Innovations at Renowned Milipol Homeland Security Event and Modern Warfare Week

Jasper Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
JSPRW

GlobeNewswire

a year ago

Jasper Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update

Eagle Point Income Company Inc. Announces 11% Increase in Common Stock Distributions for First Quarter 2024
JSPRW

Business Wire

a year ago

Eagle Point Income Company Inc. Announces 11% Increase in Common Stock Distributions for First Quarter 2024

Jasper Therapeutics to Participate at Upcoming Medical and Investor Conferences
JSPRW

GlobeNewswire

a year ago

Jasper Therapeutics to Participate at Upcoming Medical and Investor Conferences

NetSol Technologies, Inc. (NASDAQ:NTWK) Q1 2024 Earnings Call Transcript
JSPRW

Insider Monkey

a year ago

NetSol Technologies, Inc. (NASDAQ:NTWK) Q1 2024 Earnings Call Transcript

JSPRW

GlobeNewswire

a year ago

BIMI Announces Subsidiary Phenix Bio Inc.’s New Product Launch

Share on Social Networks: